Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Tuesday, 26 August 2025 ()
Eli Lilly on Tuesday said its daily weight loss pill helped patients with obesity and Type 2 diabetes shed weight in a late-stage trial, meeting the study's main goal and clearing the way for the company to file for approval of the drug globally. The treatment is inching closer to becoming a new,…
|
||||
You Might Like |
||||
